EP1144640A3 - Acides nucleiques et proteines de streptococcus pneumoniae - Google Patents
Acides nucleiques et proteines de streptococcus pneumoniaeInfo
- Publication number
- EP1144640A3 EP1144640A3 EP99934990A EP99934990A EP1144640A3 EP 1144640 A3 EP1144640 A3 EP 1144640A3 EP 99934990 A EP99934990 A EP 99934990A EP 99934990 A EP99934990 A EP 99934990A EP 1144640 A3 EP1144640 A3 EP 1144640A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- proteins
- nucleic acids
- streptococcus pneumoniae
- pneumoniae
- streptococcus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108091005461 Nucleic proteins Proteins 0.000 title 1
- 241000193998 Streptococcus pneumoniae Species 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07000680A EP1801218A3 (fr) | 1998-07-27 | 1999-07-27 | Acides nucléiques et protéines de la pneumonie à streptocoques |
EP05019268A EP1624064A3 (fr) | 1998-07-27 | 1999-07-27 | Acides nucléiques et protéines de streptococcus pneumoniae |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9816336 | 1998-07-27 | ||
GBGB9816336.3A GB9816336D0 (en) | 1998-07-27 | 1998-07-27 | Proteins |
US12532999P | 1999-03-19 | 1999-03-19 | |
US125329P | 1999-03-19 | ||
PCT/GB1999/002452 WO2000006738A2 (fr) | 1998-07-27 | 1999-07-27 | Acides nucleiques et proteines de streptococcus pneumoniae |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP05019268A Division EP1624064A3 (fr) | 1998-07-27 | 1999-07-27 | Acides nucléiques et protéines de streptococcus pneumoniae |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1144640A2 EP1144640A2 (fr) | 2001-10-17 |
EP1144640A3 true EP1144640A3 (fr) | 2001-11-28 |
Family
ID=26314124
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99934990A Withdrawn EP1144640A3 (fr) | 1998-07-27 | 1999-07-27 | Acides nucleiques et proteines de streptococcus pneumoniae |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1144640A3 (fr) |
JP (2) | JP2002521058A (fr) |
CN (1) | CN1318103A (fr) |
WO (1) | WO2000006738A2 (fr) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6800744B1 (en) | 1997-07-02 | 2004-10-05 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
CA2341268C (fr) | 1998-07-22 | 2010-10-12 | Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. | Vaccins contre le streptococcus suis et tests diagnostiques |
EP1950302B1 (fr) * | 1998-12-23 | 2012-12-05 | ID Biomedical Corporation of Quebec | Nouveaux antigènes de streptocoque |
TR200200633T2 (tr) * | 1998-12-23 | 2002-06-21 | Shire Biochem Inc. | Yeni streptococcus antijenleri |
US7128918B1 (en) | 1998-12-23 | 2006-10-31 | Id Biomedical Corporation | Streptococcus antigens |
US6887480B1 (en) | 1999-06-10 | 2005-05-03 | Medimmune, Inc. | Streptococcus pneumoniae proteins and vaccines |
DE60045721D1 (de) * | 1999-06-10 | 2011-04-21 | Medimmune Inc | Streptococcus pneumoniae Proteine und Impfstoffe |
DE10012370A1 (de) * | 2000-03-14 | 2001-09-27 | Chiron Behring Gmbh & Co | Adjuvans für Vakzinen |
US7074415B2 (en) | 2000-06-20 | 2006-07-11 | Id Biomedical Corporation | Streptococcus antigens |
EP1205552A1 (fr) * | 2000-11-09 | 2002-05-15 | ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. | Virulence de streptococci, avec ORFs de Streptococcus suis |
GB0107658D0 (en) * | 2001-03-27 | 2001-05-16 | Chiron Spa | Streptococcus pneumoniae |
GB0107661D0 (en) | 2001-03-27 | 2001-05-16 | Chiron Spa | Staphylococcus aureus |
GB0108079D0 (en) | 2001-03-30 | 2001-05-23 | Microbial Technics Ltd | Protein |
US7262024B2 (en) | 2001-12-20 | 2007-08-28 | Id Biomedical Corporation | Streptococcus antigens |
AU2003286056A1 (en) * | 2002-11-26 | 2004-06-18 | Id Biomedical Corporation | Streptococcus pneumoniae surface polypeptides |
EP2333114A1 (fr) * | 2003-04-15 | 2011-06-15 | Intercell AG | S. pneumoniae antigènes |
DK3466982T3 (da) * | 2005-04-08 | 2020-08-03 | Wyeth Llc | Separation af forurenende kontaminanter fra streptococcus pneumoniae-polysaccharid ved ph-manipulation |
GB0714963D0 (en) * | 2007-08-01 | 2007-09-12 | Novartis Ag | Compositions comprising antigens |
WO2009111337A1 (fr) | 2008-03-03 | 2009-09-11 | Irm Llc | Composés et compositions servant de modulateurs de l’activité des tlr |
WO2009115508A2 (fr) * | 2008-03-17 | 2009-09-24 | Intercell Ag | Peptides luttant contre s. pneumoniae et compositions, méthodes et utilisations associées |
EP2218457B1 (fr) * | 2009-02-16 | 2011-09-07 | Karlsruher Institut für Technologie | Peptides CD44v6 en tant qu'inhibiteurs d'infections bactériennes |
AU2010258677B2 (en) | 2009-06-10 | 2016-10-06 | Glaxosmithkline Biologicals S.A. | Benzonaphthyridine-containing vaccines |
CN107126557A (zh) | 2009-06-29 | 2017-09-05 | 健诺西生物科学公司 | 抗肺炎链球菌的疫苗和组合物 |
TWI445708B (zh) | 2009-09-02 | 2014-07-21 | Irm Llc | 作為tlr活性調節劑之化合物及組合物 |
CN102844047B (zh) | 2009-09-02 | 2017-04-05 | 诺华股份有限公司 | 含tlr活性调节剂的免疫原性组合物 |
US20120237536A1 (en) | 2009-09-10 | 2012-09-20 | Novartis | Combination vaccines against respiratory tract diseases |
WO2011057148A1 (fr) | 2009-11-05 | 2011-05-12 | Irm Llc | Composés et compositions permettant de moduler l'activité des tlr-7 |
AU2010339921B2 (en) | 2009-12-15 | 2016-08-11 | Glaxosmithkline Biologicals S.A. | Homogeneous suspension of immunopotentiating compounds and uses thereof |
US20130039947A1 (en) | 2010-03-12 | 2013-02-14 | Children's Medical Center Corporation | Novel immunogens and methods for discovery and screening thereof |
EA031379B1 (ru) | 2010-03-23 | 2018-12-28 | Новартис Аг | Соединения (липопептиды на основе цистеина) и композиции в качестве агонистов tlr2, применяемые для лечения инфекционных, воспалительных, респираторных и других заболеваний |
WO2012072769A1 (fr) | 2010-12-01 | 2012-06-07 | Novartis Ag | Epitopes rrgb de pneumocoque et combinaisons de variantes |
AU2012207089B2 (en) | 2011-01-20 | 2016-04-14 | Children's Medical Center Corporation | Vaccines and compositions against Streptococcus pneumoniae |
EP2822586A1 (fr) | 2012-03-07 | 2015-01-14 | Novartis AG | Formulations contenant un adjuvant d'antigènes de streptococcus pneumoniae |
EP2950819B1 (fr) | 2013-02-01 | 2018-03-28 | GlaxoSmithKline Biologicals SA | Administration intradermique de compositions immunologiques comprenant des agonistes des récepteurs de type toll |
EP4272750A3 (fr) * | 2013-02-07 | 2024-01-24 | Children's Medical Center, Corp. | Antigènes de protéine qui confèrent une protection contre une colonisation et/ou une maladie pneumococcique |
CN103834667B (zh) * | 2013-12-31 | 2016-08-17 | 李越希 | 化学合成的肺炎链球菌PspA蛋白胞外区基因片段及其表达、应用 |
EA202091931A1 (ru) | 2018-02-12 | 2020-11-05 | Иниммьюн Корпорейшн | ЛИГАНДЫ Toll-ПОДОБНЫХ РЕЦЕПТОРОВ |
AU2019338473A1 (en) | 2018-09-12 | 2021-05-06 | Affinivax, Inc. | Multivalent pneumococcal vaccines |
AU2019338448A1 (en) * | 2018-09-12 | 2021-05-06 | The Children's Medical Center Corporation | Pneumococcal fusion protein vaccines |
US11473093B2 (en) | 2020-11-04 | 2022-10-18 | Eligo Bioscience | Cutibacterium acnes recombinant phages, method of production and uses thereof |
US12036276B2 (en) | 2021-09-09 | 2024-07-16 | Affinivax, Inc. | Multivalent pneumococcal vaccines |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5928900A (en) * | 1993-09-01 | 1999-07-27 | The Rockefeller University | Bacterial exported proteins and acellular vaccines based thereon |
WO1997037026A1 (fr) * | 1996-04-02 | 1997-10-09 | Smithkline Beecham Corporation | Nouveaux composes |
EP0914330A4 (fr) * | 1996-05-14 | 2002-01-09 | Smithkline Beecham Corp | Composes de type nouveau |
US6420135B1 (en) * | 1996-10-31 | 2002-07-16 | Human Genome Sciences, Inc. | Streptococcus pneumoniae polynucleotides and sequences |
US6271000B1 (en) * | 1996-12-13 | 2001-08-07 | Eli Lilly And Company | Streptococcus pneumoniae gene sequence mraY |
GB9700939D0 (en) * | 1997-01-17 | 1997-03-05 | Microbial Technics Limited | Therapy |
-
1999
- 1999-07-27 CN CN99810978A patent/CN1318103A/zh active Pending
- 1999-07-27 EP EP99934990A patent/EP1144640A3/fr not_active Withdrawn
- 1999-07-27 JP JP2000562520A patent/JP2002521058A/ja active Pending
- 1999-07-27 WO PCT/GB1999/002452 patent/WO2000006738A2/fr not_active Application Discontinuation
-
2007
- 2007-08-28 JP JP2007221409A patent/JP2008022856A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1144640A2 (fr) | 2001-10-17 |
WO2000006738A2 (fr) | 2000-02-10 |
JP2002521058A (ja) | 2002-07-16 |
WO2000006738A3 (fr) | 2001-08-23 |
JP2008022856A (ja) | 2008-02-07 |
CN1318103A (zh) | 2001-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1144640A3 (fr) | Acides nucleiques et proteines de streptococcus pneumoniae | |
AU2002309130A1 (en) | Streptococcus pneumoniae proteins and nucleic acids | |
AU2002214127A1 (en) | Nucleic acids and proteins from streptococcus groups A and B | |
AU5793798A (en) | Streptococcus pneumoniae dna sequences | |
WO1999046281A8 (fr) | Nouveaux polypeptides et acides nucleiques les codant | |
AU2002214531A1 (en) | Proteins and nucleic acids encoding same | |
AU6667998A (en) | Nucleic acids encoding caspase-8h and caspase-8i | |
AU2486300A (en) | Secreted proteins and nucleic acids encoding them | |
AU2001288390A1 (en) | Proteins and nucleic acids encoding same | |
AU6280899A (en) | Secreted proteins and nucleic acids encoding them | |
AU2710400A (en) | Monocyte-derived nucleic acids and related compositions and methods | |
AU3511100A (en) | Novel nucleic acids and polypeptides | |
AU6164099A (en) | Hrpca 9 and hrpca 10 nucleic acids and polypeptides | |
AU1525499A (en) | Ikap proteins, nucleic acids and methods | |
AU5377599A (en) | Nucleic acids | |
AU2002211681A1 (en) | Proteins and nucleic acids encoding same | |
AU7756100A (en) | Interleukin-2 like protein and nucleic acids encoding same | |
AU2002227445A1 (en) | Proteins and nucleic acids encoding same | |
AU1690200A (en) | Novel protein and dna thereof | |
AU2059500A (en) | Huhdgfh nucleic acids, polypeptides, methods and uses thereof | |
AU2017201090B2 (en) | Nucleic acids and proteins from streptococcus groups A & B | |
AU1837100A (en) | Netrin-like and ependymin-like nucleic acids and polypeptides and uses thereof | |
AU2017201090A1 (en) | Nucleic acids and proteins from streptococcus groups A & B | |
AU5447999A (en) | Novel protein and dna thereof | |
AU2381700A (en) | Ndsp nucleic acids and polypeptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
PUAK | Availability of information related to the publication of the international search report |
Free format text: ORIGINAL CODE: 0009015 |
|
17P | Request for examination filed |
Effective date: 20010227 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
XX | Miscellaneous (additional remarks) |
Free format text: DERZEIT SIND DIE WIPO-PUBLIKATIONSDATEN A3 NICHT VERFUEGBAR. |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20050223 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20050906 |